世界のMSD治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global MSD Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3939
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・MSD治療の市場動向
・企業の競争状況、市場シェア
・MSD治療の種類別市場規模（OTC、Rx薬）
・MSD治療の用途別市場規模（病院、小売薬局）
・MSD治療の北米市場規模2016-2027（アメリカ、カナダ）
・MSD治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・MSD治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・MSD治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・MSD治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Amgen、Johnson & Johnson、Roche、Pfizer Inc、Eli Lilly）
・結論

Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body’s movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon

Market Analysis and Insights: Global MSD Treatment Market
The global MSD Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global MSD Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global MSD Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global MSD Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global MSD Treatment market.

Global MSD Treatment Scope and Market Size
MSD Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global MSD Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MSD Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global MSD Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global MSD Treatment Market Perspective (2016-2027)
2.2 MSD Treatment Growth Trends by Regions
2.2.1 MSD Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 MSD Treatment Historic Market Share by Regions (2016-2021)
2.2.3 MSD Treatment Forecasted Market Size by Regions (2022-2027)
2.3 MSD Treatment Industry Dynamic
2.3.1 MSD Treatment Market Trends
2.3.2 MSD Treatment Market Drivers
2.3.3 MSD Treatment Market Challenges
2.3.4 MSD Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top MSD Treatment Players by Revenue
3.1.1 Global Top MSD Treatment Players by Revenue (2016-2021)
3.1.2 Global MSD Treatment Revenue Market Share by Players (2016-2021)
3.2 Global MSD Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by MSD Treatment Revenue
3.4 Global MSD Treatment Market Concentration Ratio
3.4.1 Global MSD Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MSD Treatment Revenue in 2020
3.5 MSD Treatment Key Players Head office and Area Served
3.6 Key Players MSD Treatment Product Solution and Service
3.7 Date of Enter into MSD Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 MSD Treatment Breakdown Data by Type
4.1 Global MSD Treatment Historic Market Size by Type (2016-2021)
4.2 Global MSD Treatment Forecasted Market Size by Type (2022-2027)

5 MSD Treatment Breakdown Data by Application
5.1 Global MSD Treatment Historic Market Size by Application (2016-2021)
5.2 Global MSD Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America MSD Treatment Market Size (2016-2027)
6.2 North America MSD Treatment Market Size by Type
6.2.1 North America MSD Treatment Market Size by Type (2016-2021)
6.2.2 North America MSD Treatment Market Size by Type (2022-2027)
6.2.3 North America MSD Treatment Market Size by Type (2016-2027)
6.3 North America MSD Treatment Market Size by Application
6.3.1 North America MSD Treatment Market Size by Application (2016-2021)
6.3.2 North America MSD Treatment Market Size by Application (2022-2027)
6.3.3 North America MSD Treatment Market Size by Application (2016-2027)
6.4 North America MSD Treatment Market Size by Country
6.4.1 North America MSD Treatment Market Size by Country (2016-2021)
6.4.2 North America MSD Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe MSD Treatment Market Size (2016-2027)
7.2 Europe MSD Treatment Market Size by Type
7.2.1 Europe MSD Treatment Market Size by Type (2016-2021)
7.2.2 Europe MSD Treatment Market Size by Type (2022-2027)
7.2.3 Europe MSD Treatment Market Size by Type (2016-2027)
7.3 Europe MSD Treatment Market Size by Application
7.3.1 Europe MSD Treatment Market Size by Application (2016-2021)
7.3.2 Europe MSD Treatment Market Size by Application (2022-2027)
7.3.3 Europe MSD Treatment Market Size by Application (2016-2027)
7.4 Europe MSD Treatment Market Size by Country
7.4.1 Europe MSD Treatment Market Size by Country (2016-2021)
7.4.2 Europe MSD Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific MSD Treatment Market Size (2016-2027)
8.2 Asia-Pacific MSD Treatment Market Size by Type
8.2.1 Asia-Pacific MSD Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific MSD Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific MSD Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific MSD Treatment Market Size by Application
8.3.1 Asia-Pacific MSD Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific MSD Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific MSD Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific MSD Treatment Market Size by Region
8.4.1 Asia-Pacific MSD Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific MSD Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America MSD Treatment Market Size (2016-2027)
9.2 Latin America MSD Treatment Market Size by Type
9.2.1 Latin America MSD Treatment Market Size by Type (2016-2021)
9.2.2 Latin America MSD Treatment Market Size by Type (2022-2027)
9.2.3 Latin America MSD Treatment Market Size by Type (2016-2027)
9.3 Latin America MSD Treatment Market Size by Application
9.3.1 Latin America MSD Treatment Market Size by Application (2016-2021)
9.3.2 Latin America MSD Treatment Market Size by Application (2022-2027)
9.3.3 Latin America MSD Treatment Market Size by Application (2016-2027)
9.4 Latin America MSD Treatment Market Size by Country
9.4.1 Latin America MSD Treatment Market Size by Country (2016-2021)
9.4.2 Latin America MSD Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa MSD Treatment Market Size (2016-2027)
10.2 Middle East & Africa MSD Treatment Market Size by Type
10.2.1 Middle East & Africa MSD Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa MSD Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa MSD Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa MSD Treatment Market Size by Application
10.3.1 Middle East & Africa MSD Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa MSD Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa MSD Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa MSD Treatment Market Size by Country
10.4.1 Middle East & Africa MSD Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa MSD Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie MSD Treatment Introduction
11.1.4 AbbVie Revenue in MSD Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen MSD Treatment Introduction
11.2.4 Amgen Revenue in MSD Treatment Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson MSD Treatment Introduction
11.3.4 Johnson & Johnson Revenue in MSD Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche MSD Treatment Introduction
11.4.4 Roche Revenue in MSD Treatment Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc MSD Treatment Introduction
11.5.4 Pfizer Inc Revenue in MSD Treatment Business (2016-2021)
11.5.5 Pfizer Inc Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly MSD Treatment Introduction
11.6.4 Eli Lilly Revenue in MSD Treatment Business (2016-2021)
11.6.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global MSD Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global MSD Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global MSD Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global MSD Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global MSD Treatment Market Share by Regions (2016-2021)
Table 8. Global MSD Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global MSD Treatment Market Share by Regions (2022-2027)
Table 10. MSD Treatment Market Trends
Table 11. MSD Treatment Market Drivers
Table 12. MSD Treatment Market Challenges
Table 13. MSD Treatment Market Restraints
Table 14. Global MSD Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global MSD Treatment Market Share by Players (2016-2021)
Table 16. Global Top MSD Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MSD Treatment as of 2020)
Table 17. Ranking of Global Top MSD Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by MSD Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players MSD Treatment Product Solution and Service
Table 21. Date of Enter into MSD Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global MSD Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global MSD Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global MSD Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global MSD Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global MSD Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global MSD Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global MSD Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America MSD Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America MSD Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America MSD Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America MSD Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America MSD Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe MSD Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe MSD Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe MSD Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe MSD Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe MSD Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific MSD Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific MSD Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific MSD Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific MSD Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific MSD Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America MSD Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America MSD Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America MSD Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America MSD Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America MSD Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa MSD Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa MSD Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa MSD Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa MSD Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa MSD Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa MSD Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie MSD Treatment Product
Table 64. AbbVie Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen MSD Treatment Product
Table 69. Amgen Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson MSD Treatment Product
Table 74. Johnson & Johnson Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche MSD Treatment Product
Table 79. Roche Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Pfizer Inc Company Details
Table 82. Pfizer Inc Business Overview
Table 83. Pfizer Inc MSD Treatment Product
Table 84. Pfizer Inc Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer Inc Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly MSD Treatment Product
Table 89. Eli Lilly Revenue in MSD Treatment Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global MSD Treatment Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global MSD Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. MSD Treatment Report Years Considered
Figure 8. Global MSD Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global MSD Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global MSD Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global MSD Treatment Market Share by Regions (2022-2027)
Figure 12. Global MSD Treatment Market Share by Players in 2020
Figure 13. Global Top MSD Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MSD Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by MSD Treatment Revenue in 2020
Figure 15. Global MSD Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global MSD Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America MSD Treatment Market Share by Type (2016-2027)
Figure 19. North America MSD Treatment Market Share by Application (2016-2027)
Figure 20. North America MSD Treatment Market Share by Country (2016-2027)
Figure 21. United States MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe MSD Treatment Market Share by Type (2016-2027)
Figure 25. Europe MSD Treatment Market Share by Application (2016-2027)
Figure 26. Europe MSD Treatment Market Share by Country (2016-2027)
Figure 27. Germany MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific MSD Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific MSD Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific MSD Treatment Market Share by Region (2016-2027)
Figure 37. China MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America MSD Treatment Market Share by Type (2016-2027)
Figure 45. Latin America MSD Treatment Market Share by Application (2016-2027)
Figure 46. Latin America MSD Treatment Market Share by Country (2016-2027)
Figure 47. Mexico MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa MSD Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa MSD Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa MSD Treatment Market Share by Country (2016-2027)
Figure 53. Turkey MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE MSD Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 57. Amgen Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 60. Pfizer Inc Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in MSD Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界のアフリカトリパノソーマ症治療市場規模・現状・予測（2021年-2027年）

Global African Trypanosomiasis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0157 2021年4月 95Pages
QYResearch社発行の本調査資料では、アフリカトリパノソーマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MS-08、CBL-0137、AN-5568、GNF-6702、その他）、用途別市場規模（研究センター、病院、クリニック、そ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5404 2021年4月 94Pages
QYResearch社発行の本調査資料では、脊髄性筋萎縮症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、髄腔内）、用途別市場規模（SMAタイプ1、SMAタイプ2、SMAタイプ3、SMAタイプ4）、主要地域別市場規模（北米、アメリカ、...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年） Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Treatment Market The global Swedish P…
世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…
世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…